Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
ATMARINOMED6
Mon, 06.10.2025
Marinomed Biotech AG
Ad hoc announcement
Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
Korneuburg, October 6, 2025 - Ad hoc announcement
Following the successful recent capital measures, the Management Board of Marinomed Biotech AG, with the approval of the Supervisory Board, today decided to begin reviewing strategic options [ … ]
Tue, 16.09.2025
Marinomed Biotech AG
Ad hoc announcement
Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
Korneuburg, September 16, 2025 - Marinomed Biotech AG (the "Company") announces that the Management Board has resolved today to increase the Company's [ … ]
Mon, 01.09.2025
Marinomed Biotech AG
Ad hoc announcement
Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Korneuburg, September 1, 2025 - Marinomed Biotech AG (the "Company") announces that it has reached a basic agreement with an investor based in Germany on the key terms of an intended issue of convertible bonds to be secu [ … ]
